Morning Briefing
Summaries of health policy coverage from major news organizations
Research Roundup: The Latest Science, Discoveries, And Breakthroughs
HealthDay: Study: Cutting Less Healthy Tissue May Lower Cancer Recurrence Risk
Doctors removing cancers surgically might not need to cut away lots of healthy tissue to make sure they’ve gotten all the tumor, a new study says. For one form of childhood cancer, the chances it might come back can be lowered with less healthy tissue removal than previously thought, researchers reported recently in JAMA Surgery. (Thompson, 11/4)
MedPage Today: Novel Therapy Lands Speedy Approval For Wart-Like Airway Disease Caused By HPV
The FDA granted accelerated approval to doruxapapogene ralaplasmid and lalikinogene sifuplasmid (Voceryq) to reduce the frequency of surgical papilloma excisions in adults with recurrent respiratory papillomatosis (RRP), the agency announced late on Friday. As the first FDA-approved recombinant plasmid DNA-based immunotherapy, doruxapapogene ralaplasmid-lalikinogene sifuplasmid targets the wart-like growths that characterize RRP. The growths are caused by human papillomavirus (HPV) and develop in the airways, particularly around the larynx. (Rudd, 11/2)
MedPage Today: De-Escalated Treatment For HPV-Related Throat Cancer Gets Long-Term Supporting Data
More than 90% of patients are alive without evidence of disease at 5 years. (Bankhead, 11/3)
HealthDay: GLP-1 Drugs Show Promise In Reversing Prediabetes And Heart Risks
Cutting-edge weight-loss drugs like Ozempic and Zepbound are helping people reverse prediabetes and avoid heart attack and stroke more effectively than standard diabetes medications, a new study says. (Thompson, 11/4)
San Francisco Chronicle: UCSF Researchers Test Cilostazol To Prevent A Second Stroke
UCSF researchers this week will begin enrolling patients in a study testing whether an existing drug can help prevent a second stroke. People who’ve suffered from one ischemic stroke, the most common type of stroke, have a roughly 10% chance of having another stroke in the next five years — making the prevention of a second stroke critical. (Ho, 11/2)
Medical Xpress: Lung Antibodies Can Be Measured In Exhaled Breath
For the first time, researchers have successfully measured antibodies against specific respiratory viruses in exhaled air. The new study, involving the Karolinska Institutet, was published in eBioMedicine. The method may make it easier to study the immune system in the small airways of the lungs. (Bjorklund, 11/4)
